Clobetasol Propionate
Pricing Report NDC 40085-888-50

Latest NADAC: $1.12010 per GM · Effective Feb 19, 2020

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Clobetasol Propionate (NDC 40085-888-50) is $1.12010 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Feb 19, 2020.

As a provided by Renaissance Pharma, Inc., this medication is distributed in a 50 g in 1 CAN configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.12010
Per GM

Effective Date
Feb 19, 2020
Data Status
As of Feb 26, 2020
C/I - Chain or Independent Pharmacy
Package NDC
Description
50 g in 1 CAN
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Apr 2014, the NADAC wholesale price for (NDC ) has moved within a range of $1.10785 to $5.22013 per GM. Over this 5 years and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1.1079 - $4.7812
Market Volatility
331.57% Variance
Latest Trend
1.11%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Feb 19, 2020 $1.12010 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 22, 2020 $1.10785 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 18, 2019 $1.35473 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 18, 2019 $1.23633 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 20, 2019 $1.54311 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 20, 2019 $1.34732 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 23, 2019 $1.87081 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 23, 2019 $1.57523 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 18, 2019 $1.78983 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 21, 2019 $1.60874 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 21, 2019 $1.92020 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 21, 2019 $1.92020 GMC/I - Chain or Independent PharmacyCode 4, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026